Methodology

All entries for: Dianthus Therapeutics, Inc

March 9, 2026

Dianthus Therapeutics, Inc

Neutral Outlook

New York, NY
1-50 employees

Notwithstanding these provisions, the IRA’s impact on commercialization and competition remains largely uncertain.

Disease Area: Dermatology, Immune Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic
Source
Source
Scroll to Top